Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Cancer Res. 2011 Apr 1;71(7):2706-17. doi: 10.1158/0008-5472.CAN-10-0738. Epub 2011 Feb 15.
PIK3CA, which codes for the p110α catalytic subunit of phosphatidylinositol 3-kinase, is one of the most frequently mutated genes in human breast cancer. Here, we describe a mouse model for PIK3CA-induced breast cancer by using the ROSA26 (R26) knock-in system, in which targeted Pik3ca alleles can be activated through transgenic expression of Cre recombinase. We mated Pik3ca(H1047R) and Pik3ca(wt) knock-in lines with MMTV-Cre transgenics, which express Cre in mammary epithelium. Starting at approximately 5 months of age, female R26-Pik3ca(H1047R);MMTV-Cre mice, but not control R26-Pik3ca(wt);MMTV-Cre mice, developed mammary tumors, as well as lymphoid and skin malignancies. R26-Pik3ca(H1047R);MMTV-Cre mammary tumors were typically either adenosquamous carcinoma or adenomyoepithelioma. As p53 is the most commonly mutated gene in breast cancer, we tested for genetic interaction between Pik3ca(H1047R) and p53 loss-of-function mutations in R26-Pik3ca(H1047R);p53(loxP/+);MMTV-Cre mice. This led to decreased survival of double-mutant animals, which developed lymphoma and mammary tumors with rapid kinetics. Mammary tumors that formed in p53(loxP/+);MMTV-Cre conditional mutants were either poorly differentiated adenocarcinoma or spindle cell/EMT, whereas R26-Pik3ca(H1047R);p53(loxP/+);MMTV-Cre mammary tumors were mostly adenosquamous carcinoma or spindle cell/EMT indicating that double-mutant mice develop a distinct spectrum of mammary tumors. Thus, an oncogenic variant of PIK3CA implicated in multiple human breast cancer subtypes can induce a very diverse spectrum of mammary tumors in mice. Furthermore, Pik3ca(H1047R) shows cooperation with p53, which altered the specific tumors that formed. Thus, the two most frequently mutated genes in human breast cancer show cooperation in mammary tumor formation.
PIK3CA 编码磷脂酰肌醇 3-激酶的 p110α 催化亚基,是人类乳腺癌中突变最频繁的基因之一。在这里,我们使用 ROSA26(R26)基因敲入系统描述了一种由 PIK3CA 诱导的乳腺癌小鼠模型,在该系统中,靶向 Pik3ca 等位基因可以通过转导表达 Cre 重组酶来激活。我们将 Pik3ca(H1047R)和 Pik3ca(wt)基因敲入系与 MMTV-Cre 转基因小鼠交配,后者在乳腺上皮细胞中表达 Cre。从大约 5 个月大开始,R26-Pik3ca(H1047R);MMTV-Cre 雌性小鼠会发展为乳腺肿瘤,以及淋巴和皮肤恶性肿瘤,而对照 R26-Pik3ca(wt);MMTV-Cre 小鼠则不会。R26-Pik3ca(H1047R);MMTV-Cre 乳腺肿瘤通常为腺鳞癌或腺肌上皮癌。由于 p53 是乳腺癌中突变最常见的基因,我们测试了 Pik3ca(H1047R)与 R26-Pik3ca(H1047R);p53(loxP/+);MMTV-Cre 小鼠中 p53 功能丧失突变的遗传相互作用。这导致双突变动物的存活率降低,它们快速发展为淋巴瘤和乳腺肿瘤。p53(loxP/+);MMTV-Cre 条件性突变小鼠形成的乳腺肿瘤要么是低分化腺癌,要么是梭形细胞/EMT,而 R26-Pik3ca(H1047R);p53(loxP/+);MMTV-Cre 乳腺肿瘤主要是腺鳞癌或梭形细胞/EMT,表明双突变小鼠发展出一种独特的乳腺肿瘤谱。因此,涉及多种人类乳腺癌亚型的 PIK3CA 致癌变体可在小鼠中诱导非常多样化的乳腺肿瘤谱。此外,Pik3ca(H1047R)与 p53 合作,改变了形成的特定肿瘤。因此,人类乳腺癌中最常突变的两个基因在乳腺肿瘤形成中合作。